# A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)

> **NCT00799708** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 27 (actual)

## Conditions studied

- Postmenopause

## Interventions

- **DRUG:** Comparator: placebo
- **DRUG:** Comparator: Estrace

## Key facts

- **NCT ID:** NCT00799708
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799708, "A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00799708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*